Spots Global Cancer Trial Database for primary brain tumor
Every month we try and update this database with for primary brain tumor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Evaluation of Fluoxetine and Cytotoxic Lysosomal Stress in Glioma (FLIRT) | NCT05634707 | Primary Brain T... Brain Tumor, Re... | Fluoxetine Temozolomide | 24 Years - | Duke University | |
Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer | NCT05106296 | Ependymoma Medulloblastoma Glioblastoma Primary Brain T... | Ibrutinib Indoximod Cyclophosphamid... Etoposide | 12 Years - 25 Years | Augusta University | |
Neurocognitive Function After Proton Therapy in Children and Adolescents | NCT04066465 | Primary Brain T... | 8 Years - 18 Years | Technische Universität Dresden | ||
Intraoperative MRI and 5-ALA Guidance to Improve the Extent of Resection in Brain Tumor Surgery | NCT01798771 | Primary Maligna... Glioma Glioblastoma Metastasis | Interventional ... Control arm | 18 Years - | Johann Wolfgang Goethe University Hospital | |
Exploring Compensation to Maintain Cognitive Function in Adults Newly Diagnosed With Brain Cancer | NCT04075370 | Primary Brain T... Brain Metastase... | Neuropsychologi... | 30 Years - 65 Years | Duke University | |
Fatigue, Sleep and Cytokines in Primary Brain Tumor (PBT) Patients | NCT00876499 | Brain Cancer | Questionnaire | 18 Years - | M.D. Anderson Cancer Center | |
Radiotherapy for Malignant Astrocytomas in the Elderly | NCT00430911 | Primary Brain T... Anaplastic Astr... Glioblastoma Mu... | Radiotherapy | 70 Years - | Assistance Publique - Hôpitaux de Paris | |
Bevacizumab in the Radiation Treatment of Recurrent Malignant Glioma | NCT00595322 | Brain Cancer Recurrent Malig... Primary Brain T... | bevacizumab and... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Brain Tumor Patient-Caregiver Congruence, MD Anderson Symptom Inventory-Brain Tumor Module (MDASI-BT) | NCT00748774 | Brain Tumor | Questionnaire | 18 Years - | M.D. Anderson Cancer Center | |
Temozolomide in Elderly Patients With KPS < 70 | NCT01242566 | Primary Brain T... Glioblastoma | Temozolomide | 70 Years - | Assistance Publique - Hôpitaux de Paris | |
CBT for Insomnia in Primary Brain Tumor Patients | NCT04919993 | Primary Brain T... PBT | Cognitive Behav... | 18 Years - | Virginia Commonwealth University | |
Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer | NCT05106296 | Ependymoma Medulloblastoma Glioblastoma Primary Brain T... | Ibrutinib Indoximod Cyclophosphamid... Etoposide | 12 Years - 25 Years | Augusta University | |
Survivorship Study of Cancer Patients Who Received Cranial Radiation Therapy | NCT04567251 | Brain Metastase... Primary Brain T... Lung Cancer | 18 Years - | Duke University | ||
A Study of Avutometinib for People With Solid Tumor Cancers | NCT06104488 | Refractory Canc... CNS Tumors CNS Tumor, Adul... CNS Tumor, Chil... MAP Kinase Fami... NF1 Plexiform Neuro... Low-grade Gliom... Optic Pathway G... Neuroblastoma Primary Brain T... Solid Tumor Solid Tumor, Ad... Solid Carcinoma Central Nervous... | Avutometinib | 3 Years - 30 Years | Memorial Sloan Kettering Cancer Center | |
The Effect of Home Care Planned According to Orem in Patients With Primary Brain Tumor and Their Caregivers | NCT05328739 | Primary Brain T... Caregiver Burde... Self Care | home care | 18 Years - | TC Erciyes University | |
Bevacizumab in the Radiation Treatment of Recurrent Malignant Glioma | NCT00595322 | Brain Cancer Recurrent Malig... Primary Brain T... | bevacizumab and... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Assessment of Eloquent Function in Brain Tumor Patients | NCT01535430 | Primary Brain T... Metastatic Brai... | Brain mapping | 19 Years - | University of Nebraska | |
Non-invasive Glioma Characterization Through Molecular Imaging | NCT03684109 | Glioma Brain Tumor Primary Brain T... Malignant Gliom... Malignant Prima... | 3T MRI Scanner | 18 Years - | University of Miami | |
Bevacizumab in the Radiation Treatment of Recurrent Malignant Glioma | NCT00595322 | Brain Cancer Recurrent Malig... Primary Brain T... | bevacizumab and... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Serum DNA Analysis: Potential Application for Diagnosis and Prognosis in Brain Cancer. | NCT00265174 | Primary Brain T... | - | Hadassah Medical Organization | ||
Cognitive Function After Radiation Therapy for Brain Tumours | NCT04118426 | Primary Brain T... Radiation Toxic... | Cognitive testi... | 18 Years - 100 Years | University of Aarhus | |
Temozolomide Plus Bevacizumab in Supratentorial Glioblastoma in 70 Years and Older Patients With an Impaired Functional Status | NCT02898012 | Glioblastoma Mu... Primary Brain T... | Temozolomide Bevacizumab | 70 Years - | Assistance Publique - Hôpitaux de Paris | |
Influences of Propofol and Sevoflurane Anesthesia in Brain Tumor | NCT05141877 | Brain Tumor | Propofol Sevoflurane | 20 Years - 80 Years | Kaohsiung Medical University Chung-Ho Memorial Hospital | |
Comparison of Contrast Agents for MRI Perfusion Analysis in Brain Tumor Patients | NCT02095353 | Central Nervous... | 19 Years - | University of Nebraska | ||
Neuropharmacokinetics of Eribulin Mesylate in Treating Patients With Primary or Metastatic Brain Tumors | NCT02338037 | Metastatic Mali... Primary Brain T... | Therapeutic Con... Biopsy Eribulin Mesyla... Microdialysis Pharmacological... | 18 Years - | City of Hope Medical Center | |
Innohep for Prophylaxis of Venous Thromboembolism in Brain Tumor Patients | NCT00629447 | Primary Brain T... | Innohep | 18 Years - | Duke University | |
Executive and Socio-cognitive Functions in Survivors of Primary Brain Tumor: Impact on Patients' Quality of Life | NCT02693405 | Primary Brain T... Neurocognition Quality of Life | Executive funct... social cognitio... quality of life | 8 Years - 59 Years | University Hospital, Angers | |
Assessment of Eloquent Function in Brain Tumor Patients | NCT01535430 | Primary Brain T... Metastatic Brai... | Brain mapping | 19 Years - | University of Nebraska | |
Safety and Efficacy of Trans Sodium Crocetinate (TSC) With Radiation and Temozolomide in Newly Diagnosed Glioblastoma | NCT01465347 | Glioblastoma GBM Glioma | Trans Sodium Cr... | 18 Years - | Diffusion Pharmaceuticals Inc | |
Impact of the Development of Pediatric Palliative Care | NCT05660499 | Primary Brain T... | 1 Year - 17 Years | University Hospital, Strasbourg, France | ||
Assistance in Neurosurgery (ExtempoRMN) | NCT02272452 | Primary Brain T... Glioma | High-Resolution... | 18 Years - | University Hospital, Strasbourg, France | |
Exploring Compensation to Maintain Cognitive Function in Adults Newly Diagnosed With Brain Cancer | NCT04075370 | Primary Brain T... Brain Metastase... | Neuropsychologi... | 30 Years - 65 Years | Duke University | |
Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients | NCT05576103 | Primary Brain T... Glioma Meningioma Schwannoma | 18 Years - 99 Years | University of California, San Diego | ||
Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research | NCT05539677 | Malignant Solid... Primary Brain T... Melanoma Soft Tissue Sar... Colorectal Canc... Kidney Cancer Prostate Cancer | 1 Year - | N.N. Petrov National Medical Research Center of Oncology | ||
The Effect of Home Care Planned According to Orem in Patients With Primary Brain Tumor and Their Caregivers | NCT05328739 | Primary Brain T... Caregiver Burde... Self Care | home care | 18 Years - | TC Erciyes University |